Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%) Dr. Reddy’s Laboratories informs about press release
Date: 19-07-2019Dr. Reddy’s Laboratories has informed about Press Release on 'Dr. Reddy's announces the launch of over-the-counter, store-brand equivalent of Allegra-D 12 HR Allergy and Congestion Extended-Release Tablets (fexofenadine HCl 60 mg and pseudoephedrine HCI 120 mg) in the US Market.'
The above information is a part of company’s filings submitted to BSE.